Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Author: Lisa Levin | December 05, 2023 02:06pm

Shares of Daktronics, Inc. (NASDAQ:DAKT) moved lower during Tuesday’s session following weak quarterly results.

Daktronics posted quarterly earnings of 5 cents per share, missing market estimates of 13 cents per share. The company’s quarterly sales came in at $199.37 million versus expectations of $213.70 million, according to Benzinga Pro.

Daktronics shares declined 10.7% to $9.15 on Tuesday.

Here are some other stocks moving in today's mid-day session.

Gainers

• Meiwu Technology Company Limited (NASDAQ:WNW) shares climbed 80.6% to $0.13.
• Volato Group, Inc. (NYSE:SOAR) shares gained 72% to $15.13.
• Clearmind Medicine Inc. (NASDAQ:CMND) jumped 62.6% to $6.23 after the company announced results in its cocaine addiction treatment.
• Allarity Therapeutics, Inc. (NASDAQ:ALLR) climbed 46.9% to $0.8946 after the company announced initial results from its ongoing Phase 2 clinical trial evaluating the efficacy of stenoparib in women with advanced ovarian cancer.
• Nxu, Inc. (NASDAQ:NXU) gained 30% to $0.0361 after gaining 29% on Monday. NXU named Sarah Wyant as interim CFO, succeeding Apoorv Dwivedi.
• XBP Europe Holdings, Inc. (NASDAQ:XBP) surged 24.7% to $47.40.
• Travere Therapeutics, Inc. (NASDAQ:TVTX) gained 24% to $7.80. Travere completed successful pre-NDA meeting for FILSPARI in IgAN. Citigroup upgraded Travere Therapeutics from Neutral to Buy and raised the price target from $7 to $10.
• Harbor Custom Development, Inc. (NASDAQ:HCDI) climbed 19.4% to $1.29.
• Mercurity Fintech Holding Inc. (NASDAQ:MFH) surged 17% to $1.3806. Mercurity Fintech announced a $6 million private placement financing.
• Heart Test Laboratories, Inc. (NASDAQ:HSCS) jumped 15.7% to $0.2179. HeartSciences received FDA confirmation to change clearance pathway for MyoVista wavECG device and associated AI-ECG algorithm to a 510(k) submission from a De Novo process.
• Gyre Therapeutics, Inc. (NASDAQ:GYRE) gained 15.5% to $18.56.
• Acrivon Therapeutics, Inc. (NASDAQ:ACRV) climbed 13.2% to $5.93.
• MSP Recovery, Inc. (NASDAQ:LIFW) gained 12% to $3.7600.
• EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) rose 8.3% to $19.86.
• GitLab Inc. (NASDAQ:GTLB) rose 6.8% to $56.55 after the company posted better-than-expected results for its third quarter and issued a strong forecast for FY24.

Losers

• Replimune Group, Inc. (NASDAQ:REPL) shares fell 48.1% to $6.39 after the company announced results from the primary analysis of the CERPASS trial evaluating RP1 in combination with cemiplimab for the treatment of locally advanced or metastatic CSCC and provided initial data for all patients in the anti-PD1 failed melanoma cohort of the IGNYTE clinical trial.
• iBio, Inc. (NYSE:IBIO) dipped 42.1% to $1.5625 after the company announced pricing of a $4.5 million public offering.
• Designer Brands Inc. (NYSE:DBI) fell 31.2% to $8.81 after the company reported worse-than-expected third-quarter financial results and lowered FY23 adjusted EPS guidance.
• U Power Limited (NASDAQ:UCAR) declined 26.9% to $0.4999. U Power recently announced pricing of its registered follow-on offering.
• SilverSun Technologies, Inc. (NASDAQ:SSNT) shares fell 24.7% to $9.40 after jumping 240% on Monday. SilverSun Technologies announced Jacobs Private Equity II and minority co-investors will invest $1 billion in the company.
• NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) fell 24.2% to $1.1293. NeuroSense said it met its primary safety and tolerability & secondary clinical efficacy endpoints in its Phase 2b PARADIGM trial of PrimeC in ALS.
• JOANN Inc. (NASDAQ:JOAN) shares fell 23.7% to $0.6799 after the company reported third-quarter earnings.
• Mainz Biomed N.V. (NASDAQ:MYNZ) dipped 23% to $1.2250. Mainz Biomed reported topline results from U.S. eAArly DETECT study evaluating novel mRNA biomarkers.
• GRI Bio, Inc. (NASDAQ:GRI) shares fell 19.1% to $0.5968. GRI Bio commenced patient enrollment in Phase 2a biomarker study evaluating lead program GRI-0621 for the treatment of idiopathic pulmonary fibrosis.
• Seelos Therapeutics, Inc. (NASDAQ:SEEL) declined 18.4% to $1.60.
• America's Car-Mart, Inc. (NASDAQ:CRMT) fell 18% to $66.31 after the company reported second-quarter financial results.
• Alterity Therapeutics Limited (NASDAQ:ATHE) dipped 14.8% to $3.58. Alterity Therapeutics will host webcast to discuss ATH434 efficacy data in primates and recent clinical progress on Tuesday, Dec. 5 in the US.
• Sphere Entertainment Co. (NYSE:SPHR) declined 13.5% to $29.07. Sphere Entertainment announced a private offering of $225 million of convertible senior notes.
• Genelux Corporation (NASDAQ:GNLX) fell 12.8% to $11.85.
• Evolent Health, Inc. (NYSE:EVH) fell 10.8% to $26.15 after the company announced a proposed offering of $350M of convertible senior notes due 2029.
• Worthington Steel, Inc. (NYSE:WS) declined 9.6% to $21.82.
• Farfetch Limited (NASDAQ:FTCH) fell 9.6% to $1.1650.
• ArcBest Corporation (NASDAQ:ARCB) dipped 9.4% to $113.14.
• Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) fell 8.5% to $0.4150 after surging 12% on Monday. Virpax Pharmaceuticals recently appointed Gerald Bruce as CEO and Eric Floyd as Chairman.
• Merit Medical Systems, Inc. (NASDAQ:MMSI) shares fell 8.3% to $67.79 after the company reported a proposed private placement of $550 million of convertible senior notes.
• GameStop Corp. (NYSE:GME) fell 8.2% to $15.60.

 

Now Read This: Ethereum Falls But Remains Above This Key Level; FTX Token, Gnosis Among Top Losers

Posted In: ACRV ALLR ARCB ATHE CMND CRMT DAKT DBI EVH EYPT FTCH GME GNLX GRI GTLB GYRE HCDI HSCS IBIO JOAN